Nahdi Medical Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	9,987	9,446	8,714	8,616	8,066	8,642
Revenue Growth (YoY)	7.41%	8.41%	1.13%	6.82%	-6.67%	10.45%
Cost of Revenue	6,332	6,005	5,278	5,141	4,821	5,448
Gross Profit	3,655	3,441	3,436	3,475	3,245	3,194
Selling, General & Admin	2,778	2,598	2,499	2,500	2,397	2,269
Other Operating Expenses	-32.15	-27.91	-23.7	-24.3	-58.06	-23.08
Operating Expenses	2,746	2,570	2,475	2,475	2,339	2,228
Operating Income	908.97	871.66	960.74	999.82	905.94	966.17
Interest Expense	-102.73	-73.72	-50.46	-50.47	-78.88	-57.5
Interest & Investment Income	54.22	50.8	56.82	12.13	2.96	5.45
Currency Exchange Gain (Loss)	8.34	8.34	7.91	1.8	-	-
Other Non Operating Income (Expenses)	-42.14	-25.67	-31.47	-11.15	7.61	1.8
EBT Excluding Unusual Items	826.68	831.41	943.53	952.13	837.63	915.92
Gain (Loss) on Sale of Assets	1.54	1.54	0.22	-17.37	0.15	1.13
Asset Writedown	1.6	1.6	0.5	3.16	19.49	-22.6
Pretax Income	829.81	834.54	944.25	937.93	857.27	894.45
Income Tax Expense	17.14	13.82	51.63	50.11	44.74	45.33
Net Income	812.67	820.72	892.62	887.81	812.53	849.12
Net Income to Common	812.67	820.72	892.62	887.81	812.53	849.12
Net Income Growth	-2.49%	-8.05%	0.54%	9.26%	-4.31%	22.70%
Shares Outstanding (Basic)	130	130	130	130	130	130
Shares Outstanding (Diluted)	130	130	130	130	130	130
Shares Change (YoY)	-	-	-	-	-	2500.00%
EPS (Basic)	6.25	6.31	6.87	6.83	6.25	6.53
EPS (Diluted)	6.25	6.31	6.87	6.83	6.25	6.53
EPS Growth	-2.49%	-8.05%	0.54%	9.26%	-4.31%	-95.28%
Free Cash Flow	1,003	1,152	962.17	1,418	1,051	1,290
Free Cash Flow Per Share	7.72	8.86	7.40	10.90	8.09	9.92
Dividend Per Share	5.600	5.500	5.500	5.310	-	-
Dividend Growth	1.82%	-	3.58%	-	-	-
Gross Margin	36.60%	36.43%	39.43%	40.33%	40.23%	36.96%
Operating Margin	9.10%	9.23%	11.03%	11.60%	11.23%	11.18%
Profit Margin	8.14%	8.69%	10.24%	10.30%	10.07%	9.83%
Free Cash Flow Margin	10.04%	12.19%	11.04%	16.45%	13.04%	14.93%
EBITDA	1,192	1,130	1,181	1,192	1,070	1,110
EBITDA Margin	11.93%	11.96%	13.55%	13.84%	13.26%	12.84%
D&A For EBITDA	282.89	258.31	219.86	192.36	164.03	143.75
EBIT	908.97	871.66	960.74	999.82	905.94	966.17
EBIT Margin	9.10%	9.23%	11.03%	11.60%	11.23%	11.18%
Effective Tax Rate	2.07%	1.66%	5.47%	5.34%	5.22%	5.07%
Advertising Expenses	-	59.61	66.36	67.81	54.92	75.69

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.